Familial Otosclerosis Overview
Learn About Familial Otosclerosis
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Washington University
Nedim Durakovic is an Otolaryngologist in Saint Louis, Missouri. Dr. Durakovic and is rated as an Advanced provider by MediFind in the treatment of Familial Otosclerosis. His top areas of expertise are Acoustic Neuroma, Familial Otosclerosis, Otosclerosis, Myringotomy, and Mastoidectomy. Dr. Durakovic is currently accepting new patients.
Washington University
Jacques Herzog is an Otolaryngologist in Saint Louis, Missouri. Dr. Herzog and is rated as an Advanced provider by MediFind in the treatment of Familial Otosclerosis. His top areas of expertise are Hearing Loss, Acoustic Neuroma, Schwannoma, Infant Hearing Loss, and Mastoidectomy. Dr. Herzog is currently accepting new patients.
Joel Goebel is an Otolaryngologist in Saint Louis, Missouri. Dr. Goebel and is rated as an Advanced provider by MediFind in the treatment of Familial Otosclerosis. His top areas of expertise are Meniere Disease, Benign Paroxysmal Positional Vertigo, Vertigo, and Nonsyndromic Hearing Loss.
Summary: The goal of this observational case-control study is to evaluate the relationship between temporal bone computed tomography (CT) findings, bone mineral density (BMD), and audiological parameters in adults diagnosed with otosclerosis. The main questions it aims to answer are: Is there a correlation between temporal bone CT density values and the severity of hearing loss in otosclerosis? Do bone min...
Summary: Dexmedetomidine continuous intravenous infusion vs. remifentanil target-controlled infusion conscious sedation for stapedotomy/stapedectomy- a prospective, single-center, double-masked randomized trial The goal of this clinical trial is to compare monitored anesthesia care with continuous intravenous dexmedetomidine vs. remifentanil target-controlled infusion in patients undergoing stapedotomy or ...